Subcutaneous or oral administration of the polyunsaturated fatty acid linoleic acid prolongs survival of skin allografts in mice. Mice fed on a diet deficient in polyunsaturated fatty acids show a relative immunopotentiation, as indicated by accelerated skin allograft rejection and decreased incidence and rate of development of methylcholanthrene-induced tumors. These observations support the hypothesis that polyunsaturated fatty acids take part in immunoregulatory mechanisms.
Certain polyunsaturated fatty acids (PUFA) such as linoleic (C18:2) and arachidonic acid (C20:4) are essential constituents of mammalian diet and are important structural components of the phospholipids of plasma membranes. Earlier results of in vitro and in vivo investigations led to the proposal of the hypothesis that such PUFA may take part in immunoregulatory mechanisms (1) (2) (3) . Preliminary studies of the effects of subcutaneous (s.c.) injections of C18:2 and C20:4 have here been extended. Oral administration of C18:2 was studied too. A variety of strain combinations representing different strengths of the histocompatibility barrier-H-2 and H-3 differences and the H-Y system-has been examined.
Our conception of an immunoregulatory action of PUFA implies that decreased PUFA serum levels should potentiate cell-mediated immune (CMI) responses. To test this assumption we have also examined allograft survival in mice on PUFA-deficient diets, and the effect of such a diet on the development of methylcholanthrene-induced tumors.
MATERIALS AND METHODS Animals. Three-to 8-week-old CBA/CaCRC, A, C3H/ He/mg/CRC, Balb/c, and C57BL/10 mice were obtained from the Clinical Research Centre, Animal Division. Linoleic Acid. C18:2 (cis-9-cis-12-octadecadienoic acid), approximately 99% pure, was obtained from Sigma Chemical Co., St. Louis, Mo. It was injected subcutaneously (s.c.) under aseptic precautions into the hind leg region three times a week according to a schedule already known to prolong skin allograft survival (4, 1). Injections were carried out using a Hamilton repeating syringe and the mean dose was 10 ,l/day for 11-16 days. Oral administration was carried out by feeding the, animals (under light ether anesthesia) with the help of a soft plastic esophagus tube, the daily dose being 50 p1J of C18:2. Treatment was started on the day of grafting.
Abbreviations: PUFA, polyunsaturated fatty acids; C18:1, oleic acid (having an 18-carbon chain and one double bond); C18:2, linoleic acid (PUFA, having an 18-carbon chain and two double bonds); C20:4, arachidonic acid (PUFA, having a 20-carbon chain and four double bonds); CMI, oell-mediated immunity; s.c., subcutaneous-(ly); i.p., intraperitoneal(ly).
In a control experiment C18:2 effect on graft survival was compared with the effect of oleic acid (C18:1; cis-9-octadecenoic acid), approximately 99% pure (Sigma).
Allografts. A modification of the technique of Billingham and Medawar (5) was used for tail skin grafting. In some experiments a second graft was applied (second set) at a time when most if not all of the first grafts had been rejected (first set). First and second rejection were scored daily. Tumor cells were allografted by intraperitoneal (i.p.) injection of 3 (Fig. 2) . Oral C18:2 administration also prolonged graft survival times ( Table 2 ). This result confirms the finding of Ring et al. (6) in skin allografted rats.
PUFA-deficient diet caused a relative immunopotentiation, i.e., first and second skin allografts were rejected markedly faster than in the control diet groups (Fig. 3) . There was also a smaller incidence of methylcholanthrene-induced tumors in PUFA-deficient animals (Fig. 4) . Autoclaving the control diet likewise resulted in an acceleration of first and second set skin graft rejection similar to that found in PUFA-deficient animals, whereas autoclaving the deficient diet had no significant additional effect (Fig. 5) . C18:2 injection could abrogate the effect of PUFA deficiency (Fig. 5) .
Neither the administration of C18:2 nor PUFA deficiency caused an obvious difference between the death rates of treated and control groups.
Theta-positive cells in the spleens of allografted Balb/c mice were decreased in number when the animals were treated with C18:2 s.c. for 14 days, whereas the total number of spleen cells was found to be increased. No difference was observed between the numbers of theta-positive cells in animals on PUFA-deficient diet and their controls. However, the total numbers of spleen cells and their increase after allogeneic stimulation was significantly lower in the animals on the deficient diet ( (10) and second set (20) skin allograft rejection. In the first set it was noted that the median survival times of the grafts were greater than usual (compare Fig. 2 ). This may be due to the age of the animals, which were 9-10 weeks old at grafting (instead of 4-5 weeks) because of the diet pretreatment period. In our experience older animals tend to reject their grafts more slowly than younger ones. CD = Control diet; DD = PUFA-deficient diet.
skin allograft rejection and reduced tumor incidence in mice fed on autoclaved diets. Induction of tolerance also was affected, the animals getting autoclaved diet being more refractory to the induction. Studying immune resistance in malnutrition, Jose and Good (7) (8) (9) have shown that CMI remained intact in mice with restricted protein intake, the protein content of the diet being as low as 5% protein calories. Beyond that limit, at 3% protein calories, CMI was depressed (8) . This effect was irreversible when the mice were restricted in protein and calorie intake for 2 weeks at the time of weaning and then returned each group is given in parentheses.
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14 16 18 20 22 24 8 10 12 Oap after grafting FIG. 5. Life tables of first (a) and second (b) set skin allograft survival times in PUFA-deficient female CBA mice grafted with C3H tail skin. Number of, animals per group is shown in parentheses. DD = PUFA-deficient diet; CD = control diet; ACD = autoclaved control diet; ADD = autoclaved PUFA-deficient diet; ADDL = autoclaved PUFA-deficient diet + C18:2 s.c.
to a normal diet (9) . However, in animals fed with a moderately restricted diet CMI was found more effective, this observation being interpreted by the authors as failure of a blocking antibody to develop (7) .
Tumor-potentiating effects of PUFA-enriched diets have been interpreted by Tannenbaum and Silverstone (10) as resulting from increased efficiency of energy utilization by high fatty acid intake augmenting tumor growth. In our opinion the exercise of control by PUFA through an immunological surveillance system offers an alternative explanation for the long-known relationship of fatty acids and tumors (10) and our collected evidence supports this view.
Hopkins and West from the Australian National University have studied the influence of PUFA on experimental tu- (11) . Rats given a carcinogenic polycyclic hydrocarbon showed increased tumor incidence when fed a diet containing polyunsaturated rather than saturated fatty acids. The increased incidence was observed when PUFA was fed after and not before carcinogen administration, suggesting PUFA affects survival and proliferation of tumor cells rather than the initial event of neoplastic transforrhation.
The results of our study strongly support the hypothesis of an immunoregulatory PUFA effect taking the form of immunoinhibition by PUFA treatment and immunopotentiation in the state of PUFA deficiency (1-3) . The immunoregulatory aspect is stressed by the finding that the immunopotentiating effect of PUFA-deficient diet can be abrogated by C18:2 administration. This is in contrast to the observation mentioned above of irreversible changes in CMI induced by short-term calorie and protein deficiency (9 [125I]Iododeoxyuridine uptake by spleen lymph nodes and bone marrow of mice was found to be affected by PUFA treatment and reticuloendothelial system function as measured by a carbon uptake assay could be increased (4). Because various hormones take part in the regulation of PUFA serum and tissue levels (12), these fatty acids may represent mediators by which the hormonal system exerts influence on the regulation of immune mechanisms. Fatty acid levels have been found to be considerably higher in lymphoid cells than in cells of other organs (13) . These cells thus may be in an outstanding position for being influenced in their metabolism and function by changes in PUFA levels. Site of action and mechanisms whereby such changes are effective are not known yet. However, two points may have to be taken into account: (a) the precursor relationship between PUFA and prostaglandins, some of the latter having been found to be immunoinhibitory (14) ; and (b) the effects that changing PUFA levels in the phospholipids of plasma membranes may have on specific reactions of immunologically competent cells. Further investigations have to be carried out to clarify PUFA action in immunoregulation and an extended insight into underlying processes may provide a possibility for manipulation of CMI in relevant clinical disorders.
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